iShares China Large-Cap ETF (FXI)

Key Updates

FXI declined 2.53% to $34.70 since the May 21 report, extending YTD losses to -9.36% as regulatory headwinds overshadowed earlier diplomatic optimism. China's securities regulator imposed severe penalties on cross-border brokerages, forcing liquidation of mainland accounts within two years and signaling Beijing's determination to restrict capital outflows. Despite $1.22 billion in inflows following the Trump-Xi meeting, the regulatory crackdown and continued profit-taking in technology stocks have reversed gains, with the ETF now down 12.21% over six months. The investment thesis faces material deterioration as capital control tightening contradicts the market liberalization narrative that supported earlier bullish positioning.

Current Trend

FXI trades at $34.70, down 9.36% YTD and 12.21% over six months, establishing a clear downtrend with accelerating momentum. The ETF has declined 4.24% over five days and 4.26% over one month, indicating persistent selling pressure. Price action shows consistent lower highs since the brief rally following Trump's Beijing visit in mid-May, when the ETF gained 2.5% intraday. The current level represents a significant retreat from the $37.30 resistance established on May 14, with the ETF breaking through the $36.55 support level from May 15 and the $35.60 level from May 21. The accelerating decline rate—from -2.02% to -2.59% to -2.53% across successive reporting periods—demonstrates deteriorating technical momentum and investor confidence erosion.

Investment Thesis

The investment thesis centers on China's structural positioning in global supply chains, yuan appreciation, and potential U.S.-China trade normalization. Morgan Stanley projects 8-12% upside through Q2 2027, targeting MSCI China at 91, based on improved earnings, China's strengthening position in upstream supply chains, and currency appreciation. The bank identifies technology stocks with innovation capabilities and green energy companies as beneficiaries of China's 15th Five-Year Plan. However, this thesis now faces material headwinds from Beijing's regulatory crackdown on cross-border trading, which confiscated all illegal gains from Futu, Tiger Brokers, and Longbridge Securities, causing 25-28% share price collapses. The enforcement action reveals Beijing's priority to redirect capital toward domestic markets rather than facilitate international investment, directly contradicting assumptions of market liberalization. While the Trump-Xi summit framework contemplates tariff reductions on $30 billion in goods (approximately 10% of China's U.S. exports), concrete implementation remains absent, and geopolitical tensions over Taiwan persist.

Thesis Status

The investment thesis has materially weakened since the May 21 report. The regulatory crackdown on cross-border brokerages represents a fundamental shift in capital market policy, prioritizing domestic capital retention over international market integration. This directly undermines the liberalization narrative supporting Chinese equity valuations. While the $1.22 billion in ETF inflows following the Trump-Xi meeting initially validated diplomatic optimism, subsequent price declines demonstrate that regulatory risk now outweighs trade normalization hopes. The onshore yuan strengthening to 6.784—its strongest level since 2023—supports Morgan Stanley's currency appreciation thesis, but this positive factor is overwhelmed by capital control tightening. Technology sector weakness, with ChiNext and STAR 50 indexes falling 2.5-2.6% despite recent record highs, indicates profit-taking dominates despite innovation-driven growth potential. The thesis requires reassessment given Beijing's demonstrated willingness to sacrifice market access for capital control objectives, with the mandatory two-year liquidation timeline creating sustained selling pressure.

Key Drivers

The primary driver is China's cross-border trading crackdown, which confiscated illegal gains and mandated account liquidations within two years, signaling Beijing's determination to control capital outflows despite mainland investors' demonstrated appetite for overseas equities. This regulatory action directly impacts FXI by restricting capital flows and investor sentiment. Secondary drivers include $1.22 billion in China ETF inflows following the Trump-Xi meeting, reflecting initial diplomatic optimism that has since faded. The Trump-Xi summit produced cautious optimism but few concrete outcomes, with discussions of tariff reductions on $30 billion in goods remaining unimplemented. Morgan Stanley's upgraded targets project 8-12% upside through Q2 2027 based on earnings improvement and supply chain positioning, providing analytical support for recovery potential. However, persistent weakness in China-focused ETFs—with FXI down 11% from October highs—demonstrates sustained selling pressure overwhelming positive catalysts.

Technical Analysis

FXI exhibits deteriorating technical conditions with price at $34.70, down 9.36% YTD and trading well below key resistance levels. The ETF failed to sustain the brief rally to $37.30 on May 14 following Trump's Beijing visit, establishing that level as strong resistance. Subsequent breaks below $36.55 (May 15) and $35.60 (May 21) confirm a series of lower highs and lower lows, characteristic of an established downtrend. The acceleration in decline rates—from -2.02% to -2.59% to -2.53%—indicates increasing selling momentum rather than stabilization. The 5-day decline of -4.24% matches the 1-month decline of -4.26%, suggesting consistent rather than episodic selling pressure. The 6-month decline of -12.21% establishes a medium-term bearish trend, with the current price representing a 12.21% drawdown from the six-month high. Volume patterns show significant activity during the $1.22 billion inflow period, but subsequent price declines indicate distribution rather than accumulation. Key support now sits at the $34.70 level, with no clear technical floor established. The ETF requires a sustained move above $36.55 to invalidate the current downtrend, representing a 5.3% rally from current levels.

Bull Case

• Morgan Stanley projects 8-12% upside through Q2 2027 with MSCI China target of 91, based on improved earnings, China's strengthening position in global upstream supply chains, and yuan appreciation against the dollar, providing institutional validation for recovery potential.
• China ETFs received $1.22 billion in inflows following the Trump-Xi meeting, demonstrating significant investor appetite for Chinese equities when diplomatic conditions improve, suggesting capital stands ready to deploy on positive catalysts.
• U.S. and China are considering tariff reductions on approximately $30 billion in goods—roughly 10% of China's U.S. exports—which could reduce effective tariff rates by five percentage points, providing material earnings uplift for export-oriented companies.
• The onshore yuan strengthened to 6.784 against the dollar, reaching its strongest level since 2023 for eight consecutive days, enhancing returns for dollar-based investors and reflecting improving currency fundamentals that support asset valuations.
• China's competitive advantages in semiconductor localization, AI, and biotech development are supported by government policy alignment with the 15th Five-Year Plan, positioning technology companies for innovation-driven growth in high-value sectors.

Bear Case

• China's securities regulator imposed severe penalties on cross-border brokerages, confiscating all illegal gains and mandating two-year account liquidations, creating sustained selling pressure while signaling Beijing's priority for capital control over market liberalization, fundamentally undermining foreign investment appeal.
• Futu and Up Fintech shares collapsed 28% and 25% respectively following the regulatory announcement, with mainland clients generating 20% of Futu's revenue despite representing only 13% of clients, demonstrating the material financial impact of capital control enforcement on the investment ecosystem.
• FXI is down 11% from October highs, with MCHI down 13.6% and KWEB down 33%, reflecting broad-based weakness across Chinese equity segments that persists despite diplomatic initiatives, indicating structural rather than cyclical headwinds.
• Technology stocks led selloffs with ChiNext and STAR 50 indexes falling 2.5-2.6% despite hitting record highs the previous day, demonstrating that profit-taking dominates even in China's highest-growth sectors, while Xi warned of potential clashes over Taiwan, reintroducing geopolitical risk.
• Chinese-owned firms showed a 1.1 percentage point decline in average return on assets compared to non-Chinese owned firms post-acquisition, while nearly 40% of $3.3 trillion in Chinese global investments flow through tax havens, raising concerns about capital efficiency and transparency in Chinese corporate governance.